iBio (IBIO) News Today $0.82 -0.01 (-0.90%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.80 -0.02 (-2.65%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Why Is iBio Down Today?Toggle Visibility of Why Is iBio Down Today?iBio, Inc. (NYSE:IBIO) shares have come under pressure after Brookline Capital Management rolled out a series of EPS forecasts that point to continued losses through 2027, while broader analyst expectations for the next quarter remain mixed. Neutral Sentiment: Analysts Offer Predictions for iBio Q1 Earnings. Analysts Offer Predictions for iBio Q1 Earnings Negative Sentiment: Brookline Capital Management forecasted Q4 2025 EPS of ($0.39), FY 2025 EPS of ($1.79) (worse than the consensus of ($1.74)), and FY 2026 EPS of ($0.35). Free Report Negative Sentiment: The same Brookline report extended its EPS outlook for every quarter through FY 2027—projecting losses between ($0.08) and ($0.11) per quarter and a FY 2027 loss of ($0.38) per share. Free Report Posted 1h agoAI Generated. May Contain Errors. IBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Analysts Offer Predictions for iBio Q1 EarningsAugust 30 at 2:23 AM | americanbankingnews.comiBio Announces Closing of $50 Million Public OfferingAugust 25, 2025 | globenewswire.comiBio Announces $50 Million Public Offering AgreementAugust 22, 2025 | msn.comiBio Announces Pricing of $50 Million Public OfferingAugust 19, 2025 | globenewswire.comiBio, Inc. Announces Launch of Underwritten Public Offering of Pre-Funded Warrants and Series G WarrantsAugust 18, 2025 | quiverquant.comQiBio Announces Proposed Public OfferingAugust 18, 2025 | globenewswire.comiBio Faces Nasdaq Delisting Notice for Stock PriceAugust 1, 2025 | tipranks.comPharos IBio Co Ltd Share Price - Investing.com UKJune 30, 2025 | uk.investing.comiBio Announces Conference Call to Review Myostatin and Activin E Antibody Data and Reveal Third Target in AstralBio Collaboration on June 24 | NasdaqJune 24, 2025 | nasdaq.comiBio Advances Obesity Care with Antibody TherapiesJune 24, 2025 | tipranks.comiBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo ResultsJune 24, 2025 | globenewswire.comiBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference CallJune 23, 2025 | globenewswire.comiBio Extends Promissory Note Maturity to 2026June 18, 2025 | tipranks.comiBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 TreatmentJune 16, 2025 | globenewswire.comiBio’s First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical ModelMay 5, 2025 | finance.yahoo.comiBio's First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical ModelMay 5, 2025 | globenewswire.comiBio Reports Fiscal Third Quarter 2025 Financial ResultsMay 2, 2025 | globenewswire.comiBio, Inc.: iBio Raises $6.2 Million Through Warrant Inducement TransactionApril 30, 2025 | finanznachrichten.deiBio, Inc. Announces Agreement to Exercise Existing Warrants for $6.2 Million in Gross ProceedsApril 29, 2025 | quiverquant.comQiBio Raises $6.2 Million Through Warrant Inducement TransactionApril 29, 2025 | globenewswire.comiBio Enters Licensing Agreement for Obesity TreatmentApril 22, 2025 | tipranks.comiBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBioApril 22, 2025 | globenewswire.comiBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays BearishApril 8, 2025 | msn.comiBio Highlights Advancements in Obesity Antibody ProgramsApril 8, 2025 | tipranks.comiBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity PipelineApril 7, 2025 | globenewswire.comiBio, Inc. Advances in Therapeutics and LeadershipFebruary 21, 2025 | tipranks.comiBio to Begin Trading on the Nasdaq Stock ExchangeFebruary 19, 2025 | globenewswire.comIs Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year?February 17, 2025 | msn.comiBio Reports Fiscal Second Quarter 2025 Financial ResultsFebruary 10, 2025 | globenewswire.comiBio Inc. stock falls Monday, still outperforms marketJanuary 27, 2025 | marketwatch.comFelipe Duran Purchases 9,191 Shares of iBio, Inc. (NYSE:IBIO) StockJanuary 14, 2025 | insidertrades.comiBio closes private placement offering with board members, officersJanuary 13, 2025 | markets.businessinsider.comiBio director buys $500K in common stockJanuary 13, 2025 | markets.businessinsider.comiBio Advances Antibody Development for Obesity TreatmentJanuary 10, 2025 | tipranks.comiBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBioJanuary 7, 2025 | finance.yahoo.comiBio Inc. stock rises Monday, still underperforms marketJanuary 6, 2025 | marketwatch.comiBio Expands Pipeline with New Antibody AgreementJanuary 2, 2025 | tipranks.comiBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBioJanuary 2, 2025 | globenewswire.comiBio Inc. stock falls Wednesday, still outperforms marketDecember 18, 2024 | marketwatch.comLUCID CAPITAL MARKETS Initiates Coverage of iBio (IBIO) with Buy RecommendationDecember 18, 2024 | msn.comiBio Reports Fiscal First Quarter 2025 Financial ResultsNovember 12, 2024 | globenewswire.comDeveloping environmentally friendly wood fiber boardsNovember 8, 2024 | msn.comiBio Unveils AI-Driven Antibody Discovery StrategyOctober 23, 2024 | markets.businessinsider.comiBio and AstralBio Provide Update on Myostatin Program for ObesityOctober 10, 2024 | finance.yahoo.comStock market today: Wall Street rises toward more records as markets rally worldwideSeptember 27, 2024 | msn.comiBio Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateSeptember 20, 2024 | globenewswire.comMerck & Co., Inc. (MRK) Bank of America Global Healthcare Conference (Transcript)September 18, 2024 | seekingalpha.comiBio to Participate in Upcoming Investor ConferencesSeptember 3, 2024 | globenewswire.comiBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business DevelopmentAugust 12, 2024 | globenewswire.comStock Market Sell-Off: This Is the Single Best Investing Move You Can Make Right NowAugust 9, 2024 | fool.com Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IBIO Media Mentions By Week IBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IBIO News Sentiment▼1.111.05▲Average Medical News Sentiment IBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IBIO Articles This Week▼141▲IBIO Articles Average Week Get the Latest News and Ratings for IBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for iBio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies COEP News KALA News MNOV News GNTA News INMB News CUE News IMMX News SLGL News ALGS News ALXO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:IBIO) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBIO Stock Alerts